RESUMEN
Porcine edema disease (ED) is an enterotoxaemia that frequently occurs in 4-12 week-old piglets and results in high mortality. ED is caused by Shiga toxin 2e (Stx2e), produced by host-adapted Shiga toxin-producing Escherichia coli (STEC) strains. We constructed a recombinant protein in which the B subunit of Stx2e (Stx2eB) was linked to Cartilage Oligomeric Matrix Protein (COMP)'s pentameric domain to enhance antigenicity to induce neutralizing antibodies against Stx2e. We evaluated the efficacy of this antigen as a vaccine on the farm where ED had occurred. The suckling piglets were divided into two groups. The pigs in the vaccinated group were intramuscularly immunized with the vaccine containing 30 µg/head of Stx2eB-COMP at 1 and 4 weeks of age. The control pigs were injected with saline instead of the vaccine. The neutralizing antibody titer to Stx2e, mortality, clinical score, and body weight was evaluated up to 11 weeks after the first vaccination. In the vaccinated group, the Stx2e neutralizing antibody was detected 3 weeks after the first vaccination, its titer increased during the following weeks. The antibody was not detected in the control group during the test period. The STEC gene was detected in both groups during the test period, but a typical ED was observed only in control pigs; the mortality and clinical score were significantly lower in the vaccinated group than in the control group. These data indicate that the pentameric B subunit vaccine is effective for preventing ED and offers a promising tool for pig health control.
Asunto(s)
Antitoxinas , Edematosis Porcina , Infecciones por Escherichia coli , Escherichia coli Shiga-Toxigénica , Enfermedades de los Porcinos , Animales , Porcinos , Toxina Shiga II/genética , Infecciones por Escherichia coli/prevención & control , Infecciones por Escherichia coli/veterinaria , Edematosis Porcina/prevención & control , Anticuerpos Neutralizantes , Vacunas de Subunidad , Edema/prevención & control , Edema/veterinaria , Enfermedades de los Porcinos/prevención & controlRESUMEN
Chicken egg yolk immunoglobulin (IgY) against Shiga toxin 2e (Stx2e), a major cause of swine edema disease, was prepared to evaluate its possible clinical applications. The titer of Stx2e-specific IgY in egg yolk derived from three chickens that had been immunized with an Stx2e toxoid increased 2 weeks after primary immunization and remained high until 90 days after this immunization. Anti-Stx2e IgY was found to neutralize the toxicity of Stx2e by reacting with its A and B subunits, indicating that IgY is a cost-effective agent to develop for prophylactic foods or diagnosis kits for edema disease.
Asunto(s)
Yema de Huevo/química , Yema de Huevo/inmunología , Inmunoglobulinas/análisis , Toxina Shiga II/inmunología , Animales , Anticuerpos Neutralizantes/análisis , Antitoxinas/análisis , Pollos , Edematosis Porcina/prevención & control , PorcinosRESUMEN
The comprehensive effect size of several commercial vaccines and vaccine candidates against edema disease (ED) has not been evaluated to date. To integrate the effectiveness of ED vaccines reported so far and to compare and evaluate the posterior-effect estimates of each vaccine type with network models, we identified eligible studies (n = 12) from the electronic databases using specified search strings. Data for dichotomous outcomes (i.e., mortality and clinical symptoms) and continuous outcomes (i.e., fecal shedding and average daily gain) were extracted and analyzed. Conventional meta-analysis shows that, compared with that in non-vaccinated pigs, vaccinated animals are likely to show reduced mortality (OR = 0.07) and clinical signs of ED (OR = 0.11), and increased productivity (SMD = 0.73). Although reduced fecal shedding (SMD = - 1.29) was observed in vaccinated pigs, this could not be fully determined on insufficient grounds. In contrast to mortality and clinical symptoms, fecal shedding (I2 = 88%) and average daily gain (I2 = 85%) showed immense heterogeneity, which was attributed to the small sample size and vaccination route, respectively. According to the Bayesian network meta-analysis, the plasmid-based DNA vaccine demonstrated a better effect for all outcomes compared to other types of vaccines. However, these findings should be carefully interpreted with consideration to potential mediators, insufficient data, and inconsistent network models.
Asunto(s)
Edematosis Porcina , Infecciones por Escherichia coli , Escherichia coli Shiga-Toxigénica , Animales , Teorema de Bayes , Edema , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/prevención & control , Metaanálisis en Red , Porcinos , Eficacia de las VacunasRESUMEN
Edema disease (ED) is a common fatal disease in newly weaned piglets. To develop an effective control program for ED, we carried out a study to better understand the incidence and spread of the disease and the characteristics of the causative agent. In our study, 69 Escherichia coli strains, isolated from 92 piglets showing clinical signs of ED from 13 provinces in northern Vietnam, were positive for both the VT2e toxin and the F18 major fimbrial subunit gene fedA. Of these, 40 strains (58%) were positive for AIDA and 16 isolates carried one or more enterotoxins. Forty-six (67%) of the 69 VT2e(+)/F18(+) E. coli isolates belonged to classical serotypes (O139:K82, O141: K85, O138:K81, and O149:K91) while the remaining strains did not belong to the common serotypes in pig. Seropathotype 0139:K82(+)/VT2e(+)/F18(+)/AIDA(+) (21 isolates) was the most frequently detected ED-causing E. coli strain. High prevalence of resistance was observed to the common drugs of tetracycline, streptomycin, trimethoprim/sulfamethoxazole, amoxicillin/clavulanic acid, and spectinomycin. Multiple resistances were widely distributed with 84% of isolates resistant to five antibiotics. Sequence analysis demonstrated that the VT2e toxin is identical among E. coli strains causing ED in pig.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Edematosis Porcina/epidemiología , Edematosis Porcina/microbiología , Escherichia coli/patogenicidad , Toxina Shiga II/toxicidad , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Chlorocebus aethiops , Cartilla de ADN/genética , Edematosis Porcina/prevención & control , Incidencia , Datos de Secuencia Molecular , Análisis de Secuencia de ADN/veterinaria , Serotipificación/veterinaria , Toxina Shiga II/genética , Especificidad de la Especie , Porcinos , Células Vero , Vietnam/epidemiologíaRESUMEN
Porcine edema disease (ED) is a toxemia that is caused by enteric infection with Shiga toxin 2e (Stx2e)-producing Escherichia coli (STEC) and is associated with high mortality. Since ED occurs most frequently during the weaning period, preweaning vaccination of newborn piglets is required. We developed stx2eB-transgenic lettuce as an oral vaccine candidate against ED and examined its protective efficacy using a piglet STEC infection model. Two serially developed Stx2eB-lettuce strains, 2BN containing ingredient Stx2eB constituting a concentration level of 0.53 mg Stx2eB/g of powdered lettuce dry weight (DW) and 2BH containing ingredient Stx2eB constituting a concentration level of 2.3 mg of Stx2eB/g of powdered lettuce DW, were evaluated in three sequential experiments. Taken the results together, oral administration of Stx2eB-lettuce vaccine was suggested to relieve the pathogenic symptoms of ED in piglets challenged with virulent STEC strain. Our data suggested that Stx2eB-lettuce is a promising first oral vaccine candidate against ED.
Asunto(s)
Animales Recién Nacidos , Vacunas Bacterianas/administración & dosificación , Edematosis Porcina/etiología , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/complicaciones , Infecciones por Escherichia coli/veterinaria , Lactuca , Toxina Shiga II/inmunología , Escherichia coli Shiga-Toxigénica , Porcinos , Destete , Administración Oral , Animales , Escherichia coli Shiga-Toxigénica/patogenicidad , VirulenciaRESUMEN
F18+ Escherichia coli can cause post-weaning diarrhoea and oedema disease in pigs. These diseases are responsible for substantial economic losses, but a vaccine is not available. A good knowledge of the characteristic of the fimbriae is useful for the development of a vaccine composed of the fimbrial virulence factor. F18 fimbriae are composed of the major subunit FedA and the minor subunits FedE and the adhesin FedF. In the present study monoclonal antibodies (mAbs) against FedA and FedF were produced. In addition to their diagnostic value, these mAbs revealed a weaker interaction between FedA and FedF compared to the subunit-subunit interactions in other fimbriae, like type 1 and P pili. Further experiments are needed to investigate if this weak interaction could be one of the reasons for the slow colonisation of the small intestinal mucosa by F18+ E. coli.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Proteínas de Escherichia coli/inmunología , Escherichia coli/inmunología , Proteínas Fimbrias/inmunología , Fimbrias Bacterianas/inmunología , Adhesinas Bacterianas/inmunología , Adhesinas Bacterianas/fisiología , Animales , Anticuerpos Monoclonales/biosíntesis , Western Blotting/veterinaria , Diarrea/veterinaria , Edematosis Porcina/diagnóstico , Edematosis Porcina/microbiología , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/diagnóstico , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Infecciones por Escherichia coli/veterinaria , Proteínas de Escherichia coli/fisiología , Proteínas Fimbrias/fisiología , Ratones , Ratones Endogámicos BALB C , Porcinos , DesteteRESUMEN
Porcine edema disease (ED) is caused by Shiga toxin 2e-producing Escherichia coli (STEC). ED has become frequent in pig farms, and the use of antimicrobials has resulted in the development of antimicrobial-resistant STEC. Accordingly, the use of materials other than antimicrobials is requested for the prevention of ED. Oral administration of a heat-killed and dried cell preparation of Enterococcus faecalis strain EC-12 (EC-12) to weaning pigs was previously demonstrated to decrease animal mortality in a STEC-contaminated farm at 0.05% (w/w) dose level. In this study, pigs experimentally infected with STEC were used as a model for ED to evaluate the low dose level of EC-12 to prevent ED. Fifteen 21-day-old pigs were divided into 5 groups: STEC challenge with the basal diet, STEC challenge with EC-12 supplemented at 0.005, 0.01, or 0.05% (w/w) to the basal diet, and no STEC challenge with the basal diet. The challenge was carried out when the animals were 25, 26, and 27 days old using STEC contained in capsules resistant against gastric digestion. All pigs were euthanized at 32 days of age. The daily weight gain, feed conversion ratio, and palpebral edema were improved by supplementation with 0.05% EC-12, but not by the low dose levels. Accordingly, 0.05% level of supplementation was needed for EC-12 to improve clinical symptoms in weaning piglets infected by STEC.
Asunto(s)
Edematosis Porcina/microbiología , Edematosis Porcina/prevención & control , Enterococcus faecalis , Infecciones por Escherichia coli/veterinaria , Escherichia coli/crecimiento & desarrollo , Animales , Peso Corporal , Ciego/microbiología , ADN Bacteriano/química , ADN Bacteriano/genética , Ingestión de Alimentos , Escherichia coli/genética , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Femenino , Histocitoquímica/veterinaria , Íleon/microbiología , Masculino , Reacción en Cadena de la Polimerasa/veterinaria , ARN Ribosómico 16S/química , Toxina Shiga II/química , Toxina Shiga II/genética , PorcinosRESUMEN
BACKGROUND: In the pathogenicity of porcine edema disease (ED), which is caused by the Escherichia coli-producing F18 and Shiga toxin, F18+ fimbrial adhesins and Shiga toxin 2e (Stx2e) play pivotal roles in the colonization and enterotoxicity of this pathogen. OBJECTIVE: To develop a vaccine candidate against ED by combining three selected antigens of F18+ E. coli. METHODS: Genetically engineered Salmonella Typhimurium (ST) ghosts that express Stx2eB, FedF, and FedA were individually inserted in a ghost plasmid cassette, and the resultant plasmids were transformed into an attenuated ST (JOL912). The individual expression of Stx2eB, FedF, and FedA in JOL912 was validated by using an immunoblotting assay. RESULTS: Immunization of the ghosts in BALB/c mice led to a significant increase in antigen-specific secretory IgA and serum IgG. Significantly marked elevation of the CD3+CD4+ T cell subpopulation and lymphocyte proliferating activity in the primed splenocytes were also observed. Furthermore, mRNA of IL-4 and IFN-γ were highly upregulated in in vitro stimulated splenic T cells. Subsequently, the immunized mice showed significant protection efficacy against a lethal dose 50 of a virulent strain, resulting in approximately 85% and 92% survival rates in mice with a single- and double-dose immunization, respectively, compared to only 40% of the non-immunized controls. CONCLUSION: A mixture of the ghosts expressing these three antigens is a potential vaccine candidate for protection against the porcine edema disease.
Asunto(s)
Adhesinas Bacterianas/inmunología , Edematosis Porcina/prevención & control , Escherichia coli Enterotoxigénica/inmunología , Proteínas de Escherichia coli/inmunología , Vacunas contra Escherichia coli/inmunología , Proteínas Fimbrias/inmunología , Toxina Shiga II/inmunología , Animales , Edematosis Porcina/inmunología , Edematosis Porcina/microbiología , Femenino , Inmunidad Celular , Inmunidad Humoral , Inmunidad Mucosa , Ratones , Ratones Endogámicos BALB C , Salmonella/inmunología , Porcinos , Vacunas Sintéticas/inmunologíaRESUMEN
Edema disease caused by Escherichia coli is one of the most common diseases in postweaning piglets throughout Vietnam. Verotoxigenic E. coli (VTEC) was isolated from 197 of 261 samples (75.5%). All isolates were confirmed by basic biochemical tests and carbohydrate fermentation characteristics. Of these, 70.1% of isolates are hemolytic, 45% isolates belonged to serotypes O149:K91, possessed the VT2e gene, and was the most predominant VTEC pathotype associated with edema disease in pigs. Serogroup O139 accounted for 30% of the isolates, followed by serogroup O138 and O141 (25%). In addition to VT2e gene, the ST (72.7%) and LT (52.7%) genes were also recognized. A total of 10 representative isolates were subjected to toxigenicity testing by intraperitoneal injection in mice and experimental infection in pigs. It was shown that 100% of the mice were killed 17-24 h post injection (p.i.). All pigs experimentally infected with challenge strains and developed typical symptoms of edema disease 36-72 h p.i. A multivalent killed whole-cells vaccine containing aluminum hydroxide was prepared from 5 VTEC strains. The vaccine was 100% safe when administered by the intramuscular route into the pigs. A field trial for over 100,000 pigs (21-90 days old) showed that vaccinated pigs were protected against edema disease at a level of 90% compared to 100% of pigs from unvaccinated groups.
Asunto(s)
Vacunas Bacterianas , Edematosis Porcina/microbiología , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/veterinaria , Enfermedades de los Porcinos/prevención & control , Animales , Vacunas Bacterianas/inmunología , Diarrea/microbiología , Diarrea/prevención & control , Diarrea/veterinaria , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Hemólisis , Antígenos O/análisis , Serotipificación , Porcinos , Enfermedades de los Porcinos/microbiología , Vietnam , DesteteRESUMEN
Porcine edema disease (ED) caused by F18+ Shiga toxin 2e-producing Escherichia coli (STEC) has imposed significant economic losses in the swine industry worldwide, resulting in sudden deaths in post-weaned piglets. The flagellin protein of F18+ STEC, a structural component of the flagellar filament, is a known virulence factor that mediates adhesion and invasion to porcine epithelial cells. In this study, Salmonella inactivated by the E lysis gene and expressing the flagellin (fliC) antigen was genetically engineered utilizing a plasmid (pMMP184) carrying an efficient heterologous antigen delivery system. The resulting strain JOL1485 producing FliC was successfully inactivated by the E lysis gene cassette. Following the lysis procedure, FliC secretion and production of JOL1485 was validated by immunoblot analysis. To evaluate protective immunogenicity elicited by the constructed strain, BALB/c mice were injected with 1×108 lysed cells via the intramuscular route. The markedly elevated titers of FliC-specific IgG, IgG1 and sIgA antibodies were observed, indicating a robust Th2-associated humoral immune response was raised in the immunized mice. The proportion of CD3+ CD4+ splenic T cells and proliferative activity were also elevated in in vivo and in vitro stimulated mice splenocytes. Further, JOL1485 successfully elicited upregulated gene expression of cytokines IL-6, IL-8, IL17, IL-21, IFN-γ and TNF-α in naïve porcine peripheral blood mononuclear cells (PBMCs). The overall immune response elicited by JOL1485 conferred a significant rise of protection against a lethal virulent F18+ STEC challenge whereas all non-immunized mice died following the challenge. Our results demonstrate that fliC efficiently expressed in the genetically inactivated Salmonella strain has immunostimulatory and protective effects against a F18+ STEC lethal challenge, and may be promising as a potential vaccine candidate against ED infection.
Asunto(s)
Portadores de Fármacos , Edematosis Porcina/prevención & control , Proteínas de Escherichia coli/inmunología , Vacunas contra Escherichia coli/inmunología , Flagelina/inmunología , Vectores Genéticos , Salmonella/genética , Animales , Anticuerpos Antibacterianos/sangre , Linfocitos T CD4-Positivos/inmunología , Proliferación Celular , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Proteínas de Escherichia coli/genética , Vacunas contra Escherichia coli/administración & dosificación , Vacunas contra Escherichia coli/genética , Femenino , Flagelina/genética , Inmunoglobulina A Secretora/sangre , Inmunoglobulina G/sangre , Inyecciones Intramusculares , Ratones Endogámicos BALB C , Análisis de Supervivencia , Porcinos , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunologíaRESUMEN
Immunoprophylaxis of porcine oedema disease and post-weaning diarrhoea caused by strains of Escherichia coli expressing fimbriae F18 is an unsolved problem. The study was designed to examine whether vaccination with a live F18ac vaccine of unweaned pigs born to sows with F18ac antibody in the colostrum requires preformed fimbriae in the vaccine, and whether protection against the heterologous fimbrial variant F18ab is induced as well. Genetically susceptible pigs were vaccinated orally on three consecutive days, beginning 10 days before weaning with 10(11) CFU of an F18ac culture. Challenge with a dose of 10(7) CFU of E. coli F18 on three consecutive days was initiated 9 or 11 days after weaning. Eighteen pigs given the fimbriated F18ac vaccine and challenged with a strain of the homologous fimbrial variant were protected against colonization; mean faecal viable counts of the challenge strain were >3 log10 lower than those from the 17 non-vaccinated control pigs. The vaccinated pigs developed a significant rise of F18ac IgA serum antibodies. The 23 pigs which had received the non-fimbriated vaccine showed no significant protection and exhibited much lower serum F18ac IgA ELISA reactivities. Eighteen pigs vaccinated with the fimbriated F18ac and challenged with an F18ab strain had faecal viable counts nearly as high as those from 16 non-vaccinated control pigs. It is concluded that only oral vaccines having preformed fimbriae induce protection limited to the homologous fimbrial variant.
Asunto(s)
Vacunas Bacterianas , Infecciones por Escherichia coli/veterinaria , Escherichia coli/inmunología , Inmunización/veterinaria , Enfermedades de los Porcinos/prevención & control , Administración Oral , Pruebas de Aglutinación/veterinaria , Animales , Animales Lactantes , Anticuerpos Antibacterianos/análisis , Anticuerpos Antibacterianos/sangre , Vacunas Bacterianas/inmunología , Vacunas Bacterianas/normas , Calostro/inmunología , Diarrea/inmunología , Diarrea/prevención & control , Diarrea/veterinaria , Edematosis Porcina/inmunología , Edematosis Porcina/prevención & control , Ensayo de Inmunoadsorción Enzimática/veterinaria , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/prevención & control , Heces/microbiología , Femenino , Fimbrias Bacterianas/inmunología , Distribución Aleatoria , Porcinos , Enfermedades de los Porcinos/inmunología , Virulencia , DesteteRESUMEN
The anti-colonization effect of porcine plasma powder against experimentally induced postweaning diarrhoea and oedema disease in just weaned piglets was examined. Piglets were infected with an Escherichia coli strain expressing F18ac fimbriae and producing SLTIIv- and LT-toxins. Reduced fecal excretion of the challenge strain and protection against clinical symptoms was obtained by daily supplementation of the feed with either 90 or 45 g of plasma powder. However, the piglets receiving 90 g of plasma powder a day showed diarrhoea and reduced weight gain compared to the piglets receiving 45 g of plasma powder a day. The diarrhoea was attributed to biogenic amines released from excessive protein in the diet.
Asunto(s)
Diarrea/veterinaria , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/veterinaria , Proteínas de Escherichia coli , Escherichia coli/inmunología , Enfermedades de los Porcinos/prevención & control , Adyuvantes Inmunológicos/química , Pruebas de Aglutinación/veterinaria , Animales , Adhesión Bacteriana/inmunología , Toxinas Bacterianas/inmunología , Recuento de Colonia Microbiana/veterinaria , Diarrea/inmunología , Diarrea/prevención & control , Edematosis Porcina/inmunología , Enterotoxinas/inmunología , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/prevención & control , Heces/química , Fimbrias Bacterianas/inmunología , Plasma/inmunología , Distribución Aleatoria , Toxina Shiga II , Porcinos , Enfermedades de los Porcinos/inmunología , Aumento de PesoRESUMEN
A stable water-in-oil emulsion was injected intraperitoneally (i.p.) in piglets about 5 days before weaning to prevent post-weaning diarrhoea (PWD) and oedema disease (OD). So far more than 200,000 piglets have been treated with this adjuvant on a number of farms. On these farms the mortality rate due to PWD and OD decreased, whereas the need for antibiotic treatment declined. Experiments involving alternate application of adjuvant and physiological saline, or adjuvant treatment and no treatment at all, showed a statistically significant positive effect of adjuvant application. The effect of i.p. adjuvant application on specific and non-specific defence mechanisms were examined in well defined rat- and mouse-models, to throw light upon the mechanisms behind the observed adjuvant effect in piglets.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Diarrea/veterinaria , Edematosis Porcina/prevención & control , Enfermedades de los Porcinos/prevención & control , Adyuvantes Inmunológicos/administración & dosificación , Animales , Diarrea/inmunología , Diarrea/prevención & control , Dinoprostona , Edematosis Porcina/inmunología , Emulsiones , Inyecciones Intraperitoneales , Interferones/sangre , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Prostaglandinas E/biosíntesis , Ratas , Porcinos , Enfermedades de los Porcinos/inmunologíaRESUMEN
Oedema disease usually occurs after weaning and is due to infection with Enterotoxaemic Escherichia coli strains. A total of 240 weaned piglets were used in five groups during a 28-day period. One group (a negative control) was offered feed free of antimicrobials ad libitum, three groups were offered the same diet ad libitum supplemented with either 1.6 per cent lactic acid, 1.5 per cent citric acid or 50 p.p.m. of enrotloxacin (ENR/Baytril I.E.R. 2 5 per cent, Bayer), respectively. Finally, one group was offered the same diet but the amount offered was restricted during the first 12 days post-weaning. Groups receiving acid or ENR additions to the diet had lower mortality than the negative control group (P<0.05). The three groups on treated feed also showed significantly better growth performance and food conversion ratio than the control group (P<0.05). Both organic acids and medication with 50 p.p.m. of ENR for a 10-day period are useful in controlling and/or preventing post-weaning oedema disease.
Asunto(s)
Ácido Cítrico/administración & dosificación , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/veterinaria , Fluoroquinolonas , Ácido Láctico/administración & dosificación , Alimentación Animal , Animales , Antiinfecciosos/administración & dosificación , Antiinfecciosos/metabolismo , Peso Corporal , Ácido Cítrico/metabolismo , Suplementos Dietéticos , Edematosis Porcina/metabolismo , Edematosis Porcina/patología , Enrofloxacina , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/metabolismo , Infecciones por Escherichia coli/patología , Infecciones por Escherichia coli/prevención & control , Femenino , Intestino Delgado/microbiología , Intestino Delgado/patología , Ácido Láctico/metabolismo , Masculino , Quinolonas/administración & dosificación , Quinolonas/metabolismo , PorcinosRESUMEN
The effect of treatment with verotoxin 2e (VT2e) specific antiserum was evaluated in 3 Danish pig herds with edema disease (ED). The antiserum was prepared by immunizing horses with a VT2e toxoid. The study was performed as a randomized blind field trial with parallel treatment and control groups. There were approximately 50 piglets in each group in each of the 3 herds and 741 piglets were included in the study (244 from herd A, 249 from herd B, and 247 from herd C). Treatment groups received 2, 4, or 6 mL anti-VT2e serum intramuscularly the day before weaning. Control groups were treated with 6 mL normal horse serum or 6 mL RPMI 1640 medium as placebo. All pigs that died in the trial period (1 d before weaning to 44 d after weaning) were examined pathologically and microbiologically. Mortality due to ED, mortality due to other causes, and adverse effects due to treatment were recorded. As there was no mortality due to ED, herd B was excluded from statistical calculations on mortality. The content of horse antibodies specific to VT2e in serum from pigs was analyzed in an indirect ELISA. A higher dose of anti-VT2e serum was reflected in higher optical density values in the indirect ELISA. Transient adverse reactions, seen as vomiting, ataxia, and cyanosis, occurred shortly after the injection of horse serum in 1.5% of the pigs, and one pig died. There were no statistically significant differences in mortality due to other causes among the 3 treatment groups in herds A and C. Only pigs from which F18+, VT2e+, ST-, LT- hemolytic E. coli (0139 or O-rough) was isolated were diagnosed as dead due to ED. Deaths due to ED in the control groups were 8.1% and 12.0% in herds A and C, respectively, compared with 0% and 0.7% in the corresponding serum groups. The difference between treatment and control groups was statistically significant (P<0.0001). It was not possible to establish an effect of dose (2, 4, or 6 mL) of anti-VT2e serum, because only one pig died of ED in the treatment groups. It was concluded that passive immunization by intramuscular injection of a VT2e-specific antiserum can be used for protecting piglets against ED.
Asunto(s)
Toxinas Bacterianas/uso terapéutico , Edematosis Porcina/prevención & control , Inmunización Pasiva/veterinaria , Animales , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Edematosis Porcina/inmunología , Caballos , Sueros Inmunes , Inyecciones Intramusculares , Toxina Shiga I , Análisis de Supervivencia , PorcinosRESUMEN
Pigs in 2 herds with persistent problems with post weaning edema disease caused by infection with verotoxin-2e (VT2e)-producing Escherichia coli O139 were treated with a VT2e-toxoid vaccine. Treatment was performed as a randomized blind field trial with parallel treatment and non-vaccinated control groups. In 1 herd, a group of pigs was injected with adjuvant alone. Pigs were vaccinated at 1 and 3 wk of age and weaned at 4 wk of age. The effect of vaccination was measured by average daily weight gain (ADG), mortality due to edema disease within the 1st 4 wk after weaning, and weight at 3-6 mo of age. Pathological and microbiological examinations were performed on all pigs that died during the 1st 4 wk post weaning. Only pigs from which VT2e+, F18+ E. coli O139 was isolated were categorized as "death due to edema disease." The serological response to vaccination was evaluated by an indirect ELISA. Vaccination had a statistically significant effect on the level of antibodies specific for VT2e in both herds. Vaccination resulted in a statistically significant increase in ADG in the nursery period but not in the grower-finishing period. Vaccination had a statistically significant effect on mortality due to edema disease with an odds ratio of 0.039, indicating that there was almost total elimination of mortality due to the disease in the vaccine groups.
Asunto(s)
Toxinas Bacterianas/inmunología , Vacunas Bacterianas , Edematosis Porcina/prevención & control , Vacunación/veterinaria , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Antibacterianos/inmunología , Toxinas Bacterianas/administración & dosificación , Toxinas Bacterianas/metabolismo , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/inmunología , Edematosis Porcina/inmunología , Edematosis Porcina/mortalidad , Ensayo de Inmunoadsorción Enzimática/veterinaria , Escherichia coli/metabolismo , Femenino , Inyecciones Intramusculares/métodos , Inyecciones Intramusculares/veterinaria , Ganglios Linfáticos/patología , Modelos Biológicos , Toxina Shiga II , Método Simple Ciego , Organismos Libres de Patógenos Específicos , Porcinos , Vacunación/métodos , Aumento de Peso/fisiologíaRESUMEN
Edema disease is a common cause of illness and death loss in pigs during the first 2 weeks after weaning. The disease is an enterotoxemia caused by strains of E. coli that colonize the small intestine and produce Stx2e. Bacterial colonization is mediated by F18ab fimbriae. Susceptibility to disease is determined by presence of receptors for these fimbriae on small intestinal epithelial cells and is inherited as a dominant trait. Clinical signs and lesions are largely the result of Stx2e, which causes necrosis of endothelial and smooth muscle cells in small arteries and arterioles. Vascular damage in the brain stem with resultant infarction and malacia is the main cause of death in affected pigs. Studies conducted by veterinary researchers in the 1950s and 1960s identified the cause of the disease and provided future scientists with hypotheses to test regarding the pathogenesis. In the last two decades, studies using molecular-based techniques have allowed for the definitive identification of bacterial virulence factors that mediate intestinal colonization and vascular damage, that is, F18ab fimbriae and Stx2e. Identification of these virulence factors has provided a basis for current and future development of effective preventative measures, for example, vaccines.
Asunto(s)
Edematosis Porcina/microbiología , Infecciones por Escherichia coli/veterinaria , Escherichia coli/patogenicidad , Enfermedades Intestinales/veterinaria , Animales , Animales Recién Nacidos , Edematosis Porcina/diagnóstico , Edematosis Porcina/prevención & control , Enterotoxinas/biosíntesis , Escherichia coli/metabolismo , Infecciones por Escherichia coli/prevención & control , Enfermedades Intestinales/prevención & control , Porcinos , Virulencia , DesteteRESUMEN
Diseases are often thought to result from a single cause. Although this is sometimes the case, e.g. with a highly virulent infection such as Classical Swine Fever (CSF), more often clinical disease in swine herds results from multiple predisposing factors. This is especially true in modern intensive pig husbandry, in which the role of highly infectious diseases is limited to (nonetheless devastating) outbreaks. More important nowadays are diseases, although associated with an agent, without a clear pathogenesis. The emphasis in disease control thus far has been on treatment, eradication and prevention. This has been achieved by focusing attention on husbandry factors, such as climate, housing, hygiene, management, and nutrition. Although this approach has been successful for a number of diseases, several health problems are persistent. There are strong indications that in the latter, intrinsic animal factors are important. Successful handling of these problems requires knowledge of the (patho)physiology of the pig. In this article, several characteristics of pig physiology associated with the occurrence of disease are described. It appears that the modern (fattening) pig is exceptional among other animal species in that its cardiovascular system is mismatched to its body weight. It is argued that this particular disposition causes relatively minor disturbances to have major consequences in the pig. This concept of pig physiology is central to the understanding of the hitherto poorly understood pathogenesis of several diseases, such as oedema disease.
Asunto(s)
Crianza de Animales Domésticos , Edematosis Porcina/fisiopatología , Enfermedades de los Porcinos/fisiopatología , Porcinos/fisiología , Animales , Peso Corporal , Cruzamiento , Edematosis Porcina/etiología , Edematosis Porcina/prevención & control , Mucosa Intestinal/metabolismo , Intestinos/microbiología , Tamaño de los Órganos , Porcinos/anatomía & histología , Enfermedades de los Porcinos/etiología , Enfermedades de los Porcinos/prevención & control , TransportesRESUMEN
This review deals with the pathogenesis of the post-weaning syndrome. This syndrome includes post-weaning diarrhoea (PWD), oedema disease (OD) and endotoxin shock (ES). The role of different enteropathogenic Escherichia coli bacteria and some other predisposing factors relating to this post-weaning syndrome (PWS) are discussed. Based on intestinal pathophysiological mechanisms, some suggestions for the prevention of PWS and prospects for future research are given.
Asunto(s)
Diarrea/veterinaria , Edematosis Porcina/etiología , Choque Séptico/veterinaria , Enfermedades de los Porcinos/etiología , Destete , Animales , Atrofia , Diarrea/etiología , Diarrea/prevención & control , Edematosis Porcina/prevención & control , Infecciones por Escherichia coli/etiología , Infecciones por Escherichia coli/prevención & control , Infecciones por Escherichia coli/veterinaria , Intestinos/patología , Microvellosidades/patología , Choque Séptico/etiología , Choque Séptico/prevención & control , Porcinos , Enfermedades de los Porcinos/prevención & control , SíndromeRESUMEN
To compare the effectiveness of furazolidone and apramycin (Apralan) in the treatment of oedema disease in pigs, a trial was made on a commercial farm on which colibacillosis was a recurrent problem. Medicated feed containing 100 ppm of apramycin and 400 ppm of furazolidone respectively was given for three weeks after weaning. 112 Piglets were distributed over 10 battery houses at random. Results are summarized in Figure 1.